Delivery Order SPE2DB22D3501-SPE2DB25FXG81
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,190.25 to AmerisourceBergen Drug Corp on September 4, 2025, for OmniPod 5 Dexcom G7 insulin delivery pods (Generation 5), with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The delivery will be fulfilled from the vendor's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,603.61 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 continuous glucose monitoring system pods (Generation 5), with performance in Conshohocken, Pennsylvania. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as the prime contractor under this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a competitively awarded delivery order valued at $1,566.49 for OmniPod 5 Dexcom G7 pods (Generation 5) with a 5-second delivery interval. The order, issued on September 2, 2025, with completion targeted for September 3, 2025, represents a firm fixed-price transaction with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for OmniPod 5 Dexcom G7 generation 5 insulin infusion pods valued at $14,091.23. This firm fixed-price delivery order, which will be completed by September 12, 2025, represents a non-set-aside competitive award for pharmaceutical medical supplies to support federal healthcare needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,833.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods on September 3, 2025, with a completion date of September 4, 2025. The award is unclassified with no set-aside designation and represents a competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical and medical device distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,531.79 to AmerisourceBergen Drug Corp for OmniPod 5 with Dexcom G7 continuous glucose monitoring system (Generation 5) on June 4, 2025, with completion expected by June 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,715.24 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 insulin infusion pump pods (Generation 5) with a completion date of August 28, 2025. This non-competed delivery order utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is positioned as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $9,844.08 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pump pods. The award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a firm fixed price delivery under a non-competitive set-aside arrangement. Performance will be executed at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,549.99 to AmerisourceBergen Drug Corp on September 8, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The contract is a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition without a set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency (DLA) awarded a $46,281.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 continuous glucose monitoring pods (Generation 5) with a completion date of September 12, 2025. This non-set-aside, competitively awarded contract represents a single delivery order transaction executed on September 11, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The OmniPod 5 system represents an...